Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment.

ABSTRACT: The medical and surgical treatment strategies for women with epithelial ovarian cancer continue to evolve. In the past several years, there has been significant progress backed by landmark clinical trials. Although primary epithelial ovarian cancer is still treated with a combination of surgery and systemic therapy, more complex surgical procedures and novel therapeutics have emerged as standard of care. Cytotoxic chemotherapy and maximal surgical effort remain mainstays, but targeted therapies are becoming more widespread and new data have called into question the role of surgery for women with recurrent disease. Poly ADP-ribose polymerase inhibitors have improved progression-free survival outcomes in both the frontline and recurrent settings, and their use has become increasingly widespr

SUBMITTER: Kurnit KC 

PROVIDER: S-EPMC7737875 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature